Boston, Massachusetts, United States · Remote OK
(Final title commensurate with experience: Manager, Senior Manager, Associate Director, Director) The Institute for Clinical and Economic Review (ICER) is an innovative, independent non-profit healthcare research organiz…
Skills: Health economics, Economic evaluation, Cost-effectiveness analysis, Health technology assessment, Decision-analytic modeling
Boston, Massachusetts, United States • Remote OK
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The Health Economist will manage the development and testing of rigorous economic models to assess the costs and clinical value of healthcare interventions. They will also lead project teams, communicate findings to diverse stakeholders, and contribute to the refinement of health technology assessment methods.
Candidates must hold at least a master's degree in a quantitative field such as health economics, decision sciences, or epidemiology. Strong experience in economic modeling, exceptional writing skills, and the ability to present complex methodological concepts to broad audiences are required.
(Final title commensurate with experience: Manager, Senior Manager, Associate Director, Director)
The Institute for Clinical and Economic Review (ICER) is an innovative, independent non-profit healthcare research organization dedicated to improving the application of evidence throughout the healthcare system. ICER produces influential public reports evaluating the clinical effectiveness and value of new treatments, tests, and delivery system interventions. These reports have strongly influenced US drug pricing policy and have been used by a wide variety of public and private insurers to guide price negotiation and formulary decision-making. ICER also convenes independent appraisal committee meetings at which public deliberation occurs to ensure that all perspectives are heard, and that scientific and ethical values are addressed transparently for the benefit of the public and all policymakers. In everything we do, our organization seeks to foster an honest public dialogue about the evidence on effectiveness and value, and to translate this evidence into action to improve patient care.
Because of the role it plays in the US healthcare system, ICER has become a leader in the methods of cost-effectiveness analysis as it is applied within a broader health technology assessment framework. We are already known within the international HTA community as leaders in specific areas such as the methods for evaluating treatments for ultra-rare disorders, as well as methods for addressing distinctive assessment challenges of cell and gene therapies that represent potential cures. ICER also is a leading innovator in methods to integrate traditional cost-effectiveness analysis with empiric and qualitative measures of broader dimensions of value and contextual considerations.
ICER is looking to expand its team, which includes a diverse set of clinicians, researchers, and policy experts. We are seeking a Health Economist—final title commensurate with experience—to help lead the health technology assessment and economic evaluation activities that serve as the backbone for all our work.
Details on the specific responsibilities and minimum qualifications are provided in the sections that follow. Before going there, however, ask yourself the following questions:
If you’ve answered “yes” to each question, read on!
Under direction of the Senior Vice President for Health Economics, this individual will be responsible for managing the development and testing of rigorous economic models to assess the potential costs, cost-effectiveness, and budgetary impact of a wide range of diagnostic, prognostic, therapeutic and other clinical interventions, as well as summarizing results, producing key sections of existing reports, and consulting on multiple approaches to implement findings in practice and policy.
Candidates must have a compelling personal record of engagement with the methodological issues central to the field of health technology assessment.
The position requires a person of unquestionable integrity, with exceptional communication and presentation skills, and an ability to engage with and influence a broad range of stakeholders. Depending on experience and training, this individual may also represent ICER at a variety of external academic and policy venues and may be expected to generate white papers and academic publications to support ICER’s methods.
A master’s-level degree or higher (e.g., doctorate) in a relevant discipline such as decision sciences, health economics, operations research, biostatistics, epidemiology, or a related quantitative social science field is required.
It is not intended that the above-listed duties reflect every job duty, responsibility, or task that the employee may be called upon to perform. The employee is expected to perform all job-related duties and tasks assigned by his/her supervising manager or other authorized manager.
Working towards Fair Pricing, Fair Access, and Future Innovation
The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research institute that conducts evidence-based reviews of health care interventions, including prescription drugs, other treatments, and diagnostic tests. In collaboration with patients, clinical experts, and other key stakeholders, ICER analyzes the available evidence on the benefits and risks of these interventions to measure their value and suggest fair prices. ICER also regularly reports on the barriers to care for patients and recommends solutions to ensure fair access to prescription drugs. For more information about ICER, please visit www.icer.org.
Offices: Boston, 02108, US
Working towards Fair Pricing, Fair Access, and Future Innovation
The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research institute that conducts evidence-based reviews of health care interventions, including prescription drugs, other treatments, and diagnostic tests. In collaboration with patients, clinical experts, and other key stakeholders, ICER analyzes the available evidence on the benefits and risks of these interventions to measure their value and suggest fair prices. ICER also regularly reports on the barriers to care for patients and recommends solutions to ensure fair access to prescription drugs. For more information about ICER, please visit www.icer.org.
Offices: Boston, 02108, US
